Linking inflammation, aberrant glutamate-dopamine interaction, and post-synaptic changes: translational relevance for schizophrenia and antipsychotic treatment: a systematic review

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821 · see citing works

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · see citing works

Synaptic Pruning by Microglia Is Necessary for Normal Brain Development

Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · see citing works

Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner

Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089 · see citing works

Complement and microglia mediate early synapse loss in Alzheimer mouse models

Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · see citing works

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561 · see citing works

Schizophrenia risk from complex variation of complement component 4

Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. (2016) · Nature · doi:10.1038/nature16549 · Cited by 2,394 · see citing works

Genome-wide association study identifies five new schizophrenia loci

The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) · Nature Genetics · doi:10.1038/ng.940 · Cited by 1,919 · see citing works

Tripartite synapses: astrocytes process and control synaptic information

Perea, G., Navarrete, M., & Araque, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.001 · Cited by 1,820 · see citing works

Microglia emerge as central players in brain disease

Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767 · see citing works

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742 · see citing works

Common variants conferring risk of schizophrenia

†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677 · see citing works

Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia

Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636 · see citing works

Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6

Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605 · see citing works

Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex

McEwen, B. S., Nasca, C., & Gray, J. D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.171 · Cited by 1,574 · see citing works

Dendritic spine pathology in neuropsychiatric disorders

Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523 · see citing works

Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?

Feinberg, I. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90038-3 · Cited by 1,395 · see citing works

A Synaptically Controlled, Associative Signal for Hebbian Plasticity in Hippocampal Neurons

Magee, J. C., & Johnston, D. (1997) · Science · doi:10.1126/science.275.5297.209 · Cited by 1,303 · see citing works

Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies

Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269 · see citing works

Fast-spiking, parvalbumin ⁺ GABAergic interneurons: From cellular design to microcircuit function

Hu, H., Gan, J., & Jonas, P. (2014) · Science · doi:10.1126/science.1255263 · Cited by 1,197 · see citing works

DENDRITIC COMPUTATION

London, M., & Häusser, M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135703 · Cited by 1,149 · see citing works

Cytokines and acute neurodegeneration

Allan, S. M., & Rothwell, N. J. (2001) · Nature reviews. Neuroscience · doi:10.1038/35094583 · Cited by 1,126 · see citing works

Neuronal Cell Death

Fricker, M., Tolkovsky, A. M., Borutaitė, V., Coleman, M. P., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,122 · see citing works

The Brain on Stress: Vulnerability and Plasticity of the Prefrontal Cortex over the Life Course

McEwen, B. S., & Morrison, J. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.028 · Cited by 1,079 · see citing works

Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring

Shi, L., Fatemi, S. H., Sidwell, R. W., & Patterson, P. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00297.2003 · Cited by 1,025 · see citing works

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010 · see citing works

Neuropharmacology of quinolinic and kynurenic acids.

Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 949 · see citing works

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926 · see citing works

Maternal immune activation and abnormal brain development across CNS disorders

Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880 · see citing works

Schizophrenia: an integrated sociodevelopmental-cognitive model

Howes, O. D., & Murray, R. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62036-x · Cited by 864 · see citing works

Synaptic plasticity and dysconnection in schizophrenia

Stephan, K. E., Baldeweg, T., & Friston, K. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.005 · Cited by 841 · see citing works

Latent inhibition.

Lubow, R. E. (1973) · Psychological Bulletin · doi:10.1037/h0034425 · Cited by 793 · see citing works

Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning

Sellgren, C. M., Gracias, J., Watmuff, B., Biag, J. D., Thanos, J. M., Whittredge, P. B., Fu, T., Worringer, K. A., Brown, H. E., Wang, J. P., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0334-7 · Cited by 784 · see citing works

The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications

Hilmas, C., Pereira, E., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 772 · see citing works

Immune involvement in schizophrenia and autism: Etiology, pathology and animal models

Patterson, P. H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.016 · Cited by 766 · see citing works

Tolerance, DCs and tryptophan: much ado about IDO

Grohmann, U. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00072-3 · Cited by 766 · see citing works

Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways

The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium (2015) · Nature Neuroscience · doi:10.1038/nn.3922 · Cited by 755 · see citing works

Tumor necrosis factor alpha: A link between neuroinflammation and excitotoxicity

Olmos, G., & Lladó, J. (2014) · Mediators of Inflammation · doi:10.1155/2014/861231 · Cited by 730 · see citing works

Differential Control of Learning and Anxiety along the Dorsoventral Axis of the Dentate Gyrus

Kheirbek, M. A., Drew, L. J., Burghardt, N. S., Costantini, D. O., Tannenholz, L., Ahmari, S. E., Zeng, H., Fenton, A. A., & Hen, R. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.038 · Cited by 713 · see citing works

Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism

Malkova, N. V., Yu, C. Z., Hsiao, E. Y., Moore, M. J., & Patterson, P. H. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.01.011 · Cited by 662 · see citing works

Schizophrenia as a Disorder of Developmentally Reduced Synaptic Connectivity

McGlashan, T. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.7.637 · Cited by 655 · see citing works

To Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test

Lipska, B. K. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00137-8 · Cited by 650 · see citing works

A Glycine Site Associated with N‐Methyl‐d‐Aspartic Acid Receptors: Characterization and Identification of a New Class of Antagonists

Kessler, M., Terramani, T., Lynch, G., & Baudry, M. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb01881.x · Cited by 649 · see citing works

Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.

Müller, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby024 · Cited by 648 · see citing works

Dopamine mediates vagal modulation of the immune system by electroacupuncture

Rosas, R. T., Yehia, G., Peña, G., Mishra, P., Thompson-Bonilla, M. D. R., Moreno‐Eutímio, M. A., Arriaga‐Pizano, L., Isibasi, A., & Ulloa, L. (2014) · Nature Medicine · doi:10.1038/nm.3479 · Cited by 633 · see citing works

Stress effects on the hippocampus: a critical review

Kim, E. J., Pellman, B., & Kim, J. J. (2015) · Learning & Memory · doi:10.1101/lm.037291.114 · Cited by 620 · see citing works

A transient placental source of serotonin for the fetal forebrain

Bonnin, A., Goeden, N., Chen, K., Wilson, M. L., King, J., Shih, J. C., Blakely, R. D., Deneris, E. S., & Levitt, P. (2011) · Nature · doi:10.1038/nature09972 · Cited by 608 · see citing works

Effects of prenatal infection on brain development and behavior: A review of findings from animal models

Boksa, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.03.005 · Cited by 603 · see citing works

Dendritic spine pathology in schizophrenia

Glausier, J. R., & Lewis, D. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.044 · Cited by 581 · see citing works

Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study

Doorduin, J., de Vries, E. F. J., Willemsen, A. T. M., de Groot, J. C., Dierckx, R., & Klein, H. C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066647 · Cited by 561 · see citing works

Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia

Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001308 · Cited by 533 · see citing works

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

Keshavan, M. S., Anderson, S., & Pettergrew, J. W. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90009-4 · Cited by 525 · see citing works

Dendritic Spine "Dysgenesis" and Mental Retardation

Purpura, D. P. (1974) · Science · doi:10.1126/science.186.4169.1126 · Cited by 522 · see citing works

Common Mechanisms of Excitatory and Inhibitory Imbalance in Schizophrenia and Autism Spectrum Disorders

Gao, R., & Penzes, P. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303003028 · Cited by 516 · see citing works

Altering the course of schizophrenia: progress and perspectives

Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516 · see citing works

The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease

Clausen, M. V., Hilbers, F., & Poulsen, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00371 · Cited by 511 · see citing works

Immune Activation During Pregnancy in Rats Leads to a PostPubertal Emergence of Disrupted Latent Inhibition, Dopaminergic Hyperfunction, and Altered Limbic Morphology in the Offspring: A Novel Neurodevelopmental Model of Schizophrenia

Zuckerman, L., Rehavi, M., Nachman, R., & Weiner, I. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300248 · Cited by 501 · see citing works

Maternal Exposure to Toxoplasmosis and Risk of Schizophrenia in Adult Offspring

Brown, A. S., Schaefer, C. A., Quesenberry, C. P., Liu, L., Babulas, V. P., & Susser, E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.767 · Cited by 490 · see citing works

Efficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia

Heresco‐Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Silipo, G. S., & Lichtenstein, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.29 · Cited by 487 · see citing works

Elevated Maternal Interleukin-8 Levels and Risk of Schizophrenia in Adult Offspring

Brown, A. S., Hooton, J. W. L., Schaefer, C. A., Zhang, H., Petkova, E., Babulas, V. P., Perrin, M. A., Gorman, J. M., & Susser, E. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.889 · Cited by 484 · see citing works

The role of inflammation in schizophrenia

Müller, N., Weidinger, E., Leitner, B., & Schwarz, M. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00372 · Cited by 469 · see citing works

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia

Ozawa, K., Hashimoto, K., Kishimoto, T., Shimizu, E., Ishikura, H., & Iyo, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.031 · Cited by 467 · see citing works

Prefrontal Parvalbumin Neurons in Control of Attention

Kim, H., Ährlund‐Richter, S., Wang, X., Deisseroth, K. A., & Carlén, M. (2016) · Cell · doi:10.1016/j.cell.2015.11.038 · Cited by 456 · see citing works

Immunoneuropsychiatry — novel perspectives on brain disorders

Pape, K., Tamouza, R., Leboyer, M., & Zipp, F. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0174-4 · Cited by 455 · see citing works

Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., & Carr, V. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.88 · Cited by 453 · see citing works

Working Memory Deficit as a Core Neuropsychological Dysfunction in Schizophrenia

Silver, H., Feldman, P., Bilker, W. B., & Gur, R. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1809 · Cited by 410 · see citing works

Beneficial Antipsychotic Effects of Celecoxib Add-On Therapy Compared to Risperidone Alone in Schizophrenia

Müller, N., Riedel, M. J., Scheppach, C., Brandstätter, B., Sokullu, S., Krampe, K., Ulmschneider, M., Engel, R. R., Möller, H., & Schwarz, M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1029 · Cited by 388 · see citing works

A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia

Levkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., & Kron, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04666yel · Cited by 387 · see citing works

A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia

Tynan, R. J., Weidenhofer, J., Hinwood, M., Cairns, M. J., Day, T. A., & Walker, F. R. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.12.011 · Cited by 382 · see citing works

Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia

Steullet, P., Cabungcal, J.-H., Coyle, J., Didriksen, M., Gill, K., Grace, A. A., Hensch, T. K., LaMantia, A.-S., Lindemann, L., Maynard, T. M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.47 · Cited by 360 · see citing works

Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review

Trépanier, M. O., Hopperton, K. E., Mizrahi, R., Mechawar, N., & Bazinet, R. P. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.90 · Cited by 360 · see citing works

Maternal immune activation and autism spectrum disorder: From rodents to nonhuman and human primates

Careaga, M., Murai, T., & Bauman, M. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.10.020 · Cited by 348 · see citing works

Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update

Sommer, I. E., van Westrhenen, R., Begemann, M., de Witte, L. D., Leucht, S., & Kahn, R. S. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt139 · Cited by 342 · see citing works

TGFβ produced by IL‐10 redirected astrocytes attenuates microglial activation

Norden, D. M., Fenn, A. M., Dugan, A., & Godbout, J. P. (2014) · Glia · doi:10.1002/glia.22647 · Cited by 332 · see citing works

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6

Lin, A., Kenis, G., Bignotti, S., Tura, G. J. B., Jong, R. D., Bosmans, E., Pioli, R., Altamura, C. A., Scharpé, S., & Maes, M. H. J. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00034-6 · Cited by 321 · see citing works

Neuroinflammation in schizophrenia especially focused on the role of microglia

Monji, A., Kato, T. A., Mizoguchi, Y., Horikawa, H., Seki, Y., Kasai, M., Yamauchi, Y., Yamada, S., & Kanba, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.002 · Cited by 314 · see citing works

Information-processing deficits and thought disorder in schizophrenia

Perry, W., & BRAFF, D. L. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.363 · Cited by 311 · see citing works

Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders

Williams, J. A., Burgess, S., Suckling, J., Lalousis, P. A., Batool, F., Griffiths, S. L., Palmer, E. R., Karwath, A., Barsky, A., Gkoutos, G. V., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.0407 · Cited by 310 · see citing works

Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis

Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304 · see citing works

Inflammatory Biomarkers and Risk of Schizophrenia

Hartwig, F. P., Borges, M. C., Horta, B. L., Bowden, J., & Smith, G. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3191 · Cited by 299 · see citing works

Dendritic spines and distributed circuits

Yuste, R. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.024 · Cited by 298 · see citing works

Differentiation of Mesencephalic Progenitor Cells into Dopaminergic Neurons by Cytokines

Ling, Z. D., Potter, E. D., Lipton, J. W., & Carvey, P. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6715 · Cited by 295 · see citing works

Genetic Risk for Schizophrenia: Convergence on Synaptic Pathways Involved in Plasticity

Hall, J., Trent, S., Thomas, K. L., O’Donovan, M. C., & Owen, M. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.011 · Cited by 290 · see citing works

Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization

Howes, O. D., & McCutcheon, R. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.278 · Cited by 288 · see citing works

Molecular Mechanisms of Schizophrenia

Lang, U. E., Puls, I., Müller, D. J., Strutz‐Seebohm, N., & Gallinat, J. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110430 · Cited by 281 · see citing works

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment

Chaudhry, I. B., Hallak, J. E. C., Husain, N., Minhas, F., Stirling, J., Richardson, P., Dursun, S. M., Dunn, G., & Deakin, J. F. W. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444941 · Cited by 281 · see citing works

Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia

Kindler, J., Lim, C. K., Weickert, C., Boerrigter, D., Galletly, C., Liu, D., Jacobs, K. R., Balzan, R., Bruggemann, J. M., O'Donnell, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0401-9 · Cited by 267 · see citing works

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders

Laan, W., Grobbee, D. E., Selten, J., Heijnen, C. J., Kahn, R. S., & Burger, H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05117yel · Cited by 265 · see citing works

Maternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal brain

Goeden, N., Velasquez, J., Arnold, K. A., Chan, Y., Lund, B. T., Anderson, G. M., & Bonnin, A. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2534-15.2016 · Cited by 264 · see citing works

Association Between Prenatal Exposure to Bacterial Infection and Risk of Schizophrenia

Sørensen, H. J., Mortensen, E. L., Reinisch, J. M., & Mednick, S. A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn121 · Cited by 261 · see citing works

Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology

Abazyan, B., Nomura, J., Kannan, G., Ishizuka, K., Tamashiro, K. L., Nucifora, F., Pogorelov, V., Ladenheim, B., Yang, C., Krasnova, I. N., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.022 · Cited by 255 · see citing works

Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond

Meyer, U., Schwarz, M., & Müller, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.003 · Cited by 255 · see citing works

Brain-Derived Neurotrophic Factor-Dependent Synaptic Plasticity Is Suppressed by Interleukin-1β via p38 Mitogen-Activated Protein Kinase

Tong, L., Prieto, G. A., Kramár, E. A., Smith, E. D., Cribbs, D. H., Lynch, G., & Cotman, C. W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1253-12.2012 · Cited by 254 · see citing works

Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

Müller, N., Krause, D., Dehning, S., Musil, R., Schennach-Wolff, R., Obermeier, M., Möller, H., Klauß, V., Schwarz, M., & Riedel, M. J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.04.015 · Cited by 251 · see citing works

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats

Onwordi, E. C., Halff, E. F., Whitehurst, T., Mansur, A., Cotel, M.-C., Wells, L., Creeney, H., Bonsall, D., Rogdaki, M., Shatalina, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14122-0 · Cited by 243 · see citing works

Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia

Winter, C., Djodari-Irani, A., Sohr, R., Morgenstern, R., Feldon, J., Juckel, G., & Meyer, U. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009206 · Cited by 242 · see citing works

Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia

Bitanihirwe, B. K., Peleg-Raibstein, D., Mouttet, F., Feldon, J., & Meyer, U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.129 · Cited by 237 · see citing works

Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases

Levite, M. (2015) · Acta Physiologica · doi:10.1111/apha.12476 · Cited by 236 · see citing works

The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia

Cohen, S. M., Tsien, R. W., GOFF, D. C., & Halassa, M. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.026 · Cited by 233 · see citing works

Prenatal Exposure to Maternal Genital and Reproductive Infections and Adult Schizophrenia

Babulas, V. P., Factor-Litvak, P. R., Goetz, R. R., Schaefer, C. A., & Brown, A. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.927 · Cited by 233 · see citing works

Effects of Clozapine on Plasma Cytokine and Soluble Cytokine Receptor Levels

Pollmächer, T., Hinze‐Selch, D., & Mullington, J. M. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00011 · Cited by 232 · see citing works

Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine

Cabungcal, J.-H., Steullet, P., Kraftsik, R., Cuenod, M., & Do, K. Q. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.020 · Cited by 232 · see citing works

Local Pruning of Dendrites and Spines by Caspase-3-Dependent and Proteasome-Limited Mechanisms

Ertürk, A., Wang, Y., & Sheng, M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3121-13.2014 · Cited by 231 · see citing works

Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: Identification of subgroups with immune responses and blood–CSF barrier dysfunction

Bechter, K., Reiber, H., Herzog, S., Fuchs, D., Tumani, H., & Maxeiner, H. G. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.008 · Cited by 230 · see citing works

Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models

Pillinger, T., D’Ambrosio, E., McCutcheon, R., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0058-9 · Cited by 230 · see citing works

Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia

Upthegrove, R., & Khandaker, G. M. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_88 · Cited by 230 · see citing works

Synapse elimination and learning rules co-regulated by MHC class I H2-Db

Lee, H., Brott, B. K., Kirkby, L. A., Adelson, J. D., Cheng, S., Feller, M. B., Datwani, A., & Shatz, C. J. (2014) · Nature · doi:10.1038/nature13154 · Cited by 228 · see citing works

How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis

Cannon, T. D. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.09.009 · Cited by 228 · see citing works

Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8

Ellman, L. M., Deicken, R. F., Vinogradov, S., Kremen, W. S., Poole, J. H., Kern, D. M., Tsai, W. Y., Schaefer, C. A., & Brown, A. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.014 · Cited by 225 · see citing works

Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis

Tourjman, V., Kouassi, É., Koué, M.-È., Rocchetti, M., Fortin-Fournier, S., Fusar-Poli, P., & Potvin, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.011 · Cited by 224 · see citing works

Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment

Mattei, D., Ivanov, A., Ferrai, C., Jordan, P., Guneykaya, D., Buonfiglioli, A., Schaafsma, W., Przanowski, P., Deuther-Conrad, W., Brust, P., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.80 · Cited by 222 · see citing works

A Longitudinal Examination of the Neurodevelopmental Impact of Prenatal Immune Activation in Mice Reveals Primary Defects in Dopaminergic Development Relevant to Schizophrenia

Vuillermot, S., Weber, L., Feldon, J., & Meyer, U. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5408-09.2010 · Cited by 217 · see citing works

An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis

Çakici, N., van Beveren, N. J. M., Judge-Hundal, G., Koola, M. M., & Sommer, I. E. (2019) · Psychological Medicine · doi:10.1017/s0033291719001995 · Cited by 215 · see citing works

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

Müller, N., & Schwarz, M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033242 · Cited by 214 · see citing works

Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates

Felger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214 · see citing works

Prenatal infection leads to ASD-like behavior and altered synaptic pruning in the mouse offspring

de Cossío, L. F., Guzman, A. S., van der Veldt, S., & Luheshi, G. N. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.028 · Cited by 214 · see citing works

Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials

Nitta, M., Kishimoto, T., Müller, N., Weiser, M., Davidson, M., Kane, J. M., & Correll, C. U. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt070 · Cited by 204 · see citing works

The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation

Comer, A. L., Carrier, M., Tremblay, M., & Cruz‐Martín, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00274 · Cited by 204 · see citing works

Elevated Maternal C-Reactive Protein and Increased Risk of Schizophrenia in a National Birth Cohort

Canetta, S., Sourander, A., Surcel, H.-M., Hinkka-Yli-Salomäki, S., Leiviskä, J., Kellendonk, C., McKeague, I. W., & Brown, A. S. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121579 · Cited by 203 · see citing works

Reduced Prepulse Inhibition as a Biomarker of Schizophrenia

Mena, A., Ruiz-Salas, J. C., Puentes, A., Dorado, I., Ruíz-Veguilla, M., & la Casa, L. G. D. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00202 · Cited by 203 · see citing works

Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons

Canetta, S., Bolkan, S., Padilla-Coreano, N., Song, L. J., Sahn, R., Harrison, N. L., Gordon, J. A., Brown, A., & Kellendonk, C. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.222 · Cited by 201 · see citing works

MHCI negatively regulates synapse density during the establishment of cortical connections

Glynn, M. W., Elmer, B. M., Garay, P. A., Liu, X.-B., Needleman, L. A., El-Sabeawy, F., & McAllister, A. K. (2011) · Nature Neuroscience · doi:10.1038/nn.2764 · Cited by 198 · see citing works

Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review

Misiak, B., Stańczykiewicz, B., Kotowicz, K., RYBAKOWSKI, J. K., Samochowiec, J., & Frydecka, D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.015 · Cited by 198 · see citing works

Disturbed Structural Connectivity in Schizophrenia Primary Factor in Pathology or Epiphenomenon?

Konrad, A., & Winterer, G. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm034 · Cited by 197 · see citing works

Schizophrenia and influenza at the centenary of the 1918–1919 Spanish Influenza Pandemic: mechanisms of psychosis risk

Kępińska, A. P., Iyegbe, C. O., Vernon, A. C., Yolken, R., Murray, R. M., & Pollak, T. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00072 · Cited by 193 · see citing works

A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis

Pillinger, T., Osimo, E. F., Brugger, S., Mondelli, V., McCutcheon, R. A., & Howes, O. D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby160 · Cited by 190 · see citing works

The Role of Maternal Immune Activation in the Pathogenesis of Autism: A Review of the Evidence, Proposed Mechanisms and Implications for Treatment

Zawadzka, A., Cieślik, M., & Adamczyk, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111516 · Cited by 190 · see citing works

Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia

Hwang, Y., Kim, J., Shin, J.-Y., Kim, J.-I., Seo, J.-S., Webster, M. J., Lee, D., & Kim, S. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.94 · Cited by 189 · see citing works

Silencing of TGFβ signalling in microglia results in impaired homeostasis

Zöller, T., Schneider, A., Kleimeyer, C., Masuda, T., Potru, P. S., Pfeifer, D., Blank, T., Prinz, M., & Spittau, B. (2018) · Nature Communications · doi:10.1038/s41467-018-06224-y · Cited by 189 · see citing works

Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study

Frydecka, D., Krzystek‐Korpacka, M., Lubeiro, A., Stramecki, F., Stańczykiewicz, B., Beszłej, J. A., Piotrowski, P., Kotowicz, K., Szewczuk-Bogusławska, M., Pawlak, E., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.002 · Cited by 179 · see citing works

Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106

Takano, A., Arakawa, R., Ito, H., Tateno, A., Takahashi, H., Matsumoto, R., Okubo, Y., & Suhara, T. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000313 · Cited by 174 · see citing works

MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells

Healy, L. M., Perron, G., Won, S.-Y., Michell-Robinson, M. A., Rezk, A., Ludwin, S. K., Moore, C. S., Hall, J. A., Bar-Or, A., & Antel, J. P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502562 · Cited by 174 · see citing works

Disruption of Prepulse Inhibition of Startle Reflex in a Neurodevelopmental Model of Schizophrenia Reversal by Clozapine, Olanzapine and Risperidone But Not by Haloperidol

Pen, G. L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00383-9 · Cited by 173 · see citing works

Long-Lasting Rescue of Network and Cognitive Dysfunction in a Genetic Schizophrenia Model

Mukherjee, A., Carvalho, F., Eliez, S., & Caroni, P. (2019) · Cell · doi:10.1016/j.cell.2019.07.023 · Cited by 169 · see citing works

Inflammation in first‐episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta‐analysis

Dunleavy, C., Elsworthy, R. J., Upthegrove, R., Wood, S. J., & Aldred, S. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13416 · Cited by 169 · see citing works

Non-muscle myosin II in disease: mechanisms and therapeutic opportunities

Litwa, K., Horwitz, R., & Lamers, M. L. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.022103 · Cited by 167 · see citing works

Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro

Jarskog, L. F., Xiao, H., Wilkie, M. B., Lauder, J. M., & Gilmore, J. H. (1997) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(97)00029-4 · Cited by 163 · see citing works

Animal models of obsessive-compulsive disorder: Exploring pharmacology and neural substrates

Albelda, N. S., & Joel, D. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.006 · Cited by 163 · see citing works

The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia

Roomruangwong, C., Noto, C. D. S., Kanchanatawan, B., Anderson, G., Kubera, M., Carvalho, A. F., & Maes, M. H. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01737-z · Cited by 162 · see citing works

Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages

Grent-‘t-Jong, T., Groß, J., Goense, J. B. M., Wibral, M., Gajwani, R., Gumley, A. I., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., Schröder, T. N., et al. (2018) · eLife · doi:10.7554/elife.37799 · Cited by 161 · see citing works

Effects of Antipsychotics on the Inflammatory Response System of Patients with Schizophrenia in Peripheral Blood Mononuclear Cell Cultures

Al-Amin, M. M., Uddin, M. M. N., & Reza, H. M. (2013) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2013.11.3.144 · Cited by 159 · see citing works

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics

Maes, M. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00062-0 · Cited by 156 · see citing works

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset

Chan, M. K., Krebs, M., Cox, D., Guest, P. C., Yolken, R. H., Rahmoune, H., Rothermundt, M., Steiner, J. H., Leweke, F. M., van Beveren, N. J. M., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.91 · Cited by 155 · see citing works

Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?

Jones, A. L., Mowry, B. J., Pender, M. P., & Greer, J. M. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01305.x · Cited by 155 · see citing works

Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder

Barley, K. M., Dracheva, S. M., & Byne, W. M. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.019 · Cited by 155 · see citing works

Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography

Versijpt, J. J., Dumont, F., van Laere, K. J., Decoo, D., Santens, P., Audenaert, K., Achten, E., Slegers, G., Dierckx, R., & Korf, J. (2003) · European Neurology · doi:10.1159/000070857 · Cited by 152 · see citing works

SERPINA3 (aka alpha-1-antichymotrypsin)

Baker, C. (2007) · Frontiers in bioscience · doi:10.2741/2275 · Cited by 150 · see citing works

Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF

Rothermundt, M., Falkai, P., Ponath, G. D., Abel, S., Bürkle, H., Diedrich, M., Hetzel, G., Peters, M., Siegmund, A., Pedersen, A., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001548 · Cited by 148 · see citing works

The Role of Inflammation in the Treatment of Schizophrenia

Fond, G. B., Lançon, C., Korchia, T., Auquier, P., & Boyer, L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00160 · Cited by 147 · see citing works

Maternal Immune Activation during Gestation Interacts withDisc1Point Mutation to Exacerbate Schizophrenia-Related Behaviors in Mice

Lipina, T. V., Zai, C. C. H., Hlousek, D., Roder, J., & Wong, A. H. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0091-13.2013 · Cited by 146 · see citing works

Potent Inhibition of Both Human Interferon-γ Production and Biologic Activity by the Clara Cell Protein CC16

Dierynck, I., Bernard, A., Roels, H. A., & LEY, M. D. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.12.2.7865218 · Cited by 145 · see citing works

Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist

Song, C., Lin, A., Kenis, G., Bosmans, E., & Maes, M. H. J. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00116-4 · Cited by 145 · see citing works

COX-2 inhibition as a treatment approach in schizophrenia: Immunological considerations and clinical effects of celecoxib add-on therapy

M�ller, N., Ulmschneider, M., Scheppach, C., Schwarz, M., Ackenheil, M., M�ller, H.-J., Gruber, R., & Riedel, M. J. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0478-1 · Cited by 143 · see citing works

Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features

Forsyth, J. K., & Lewis, D. A. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.06.006 · Cited by 143 · see citing works

Cortical circuit dysfunction and cognitive deficits in schizophrenia – implications for preemptive interventions

Lewis, D. A. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08156.x · Cited by 142 · see citing works

Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity

Pedrini, M., Massuda, R., Fries, G. R., Pasquali, M. A. D. B., Schnorr, C. E., Moreira, J. C. F., Teixeira, A. L., Lobato, M. I. R., Walz, J. C., Belmonte-de-Abreu, P. S., et al. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.019 · Cited by 142 · see citing works

Updating the mild encephalitis hypothesis of schizophrenia

Bechter, K. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.019 · Cited by 141 · see citing works

Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons

Potter, E. D., Ling, Z. D., & Carvey, P. M. (1999) · Cell and Tissue Research · doi:10.1007/s004410051285 · Cited by 141 · see citing works

Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia

Anderson, G., Berk, M., Dodd, S., Bechter, K., Altamura, A. C., Dell’Osso, B. M., Kanba, S., Monji, A., Fatemi, S. H., Buckley, P. F., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.008 · Cited by 140 · see citing works

Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies

Giovanoli, S., Weber‐Stadlbauer, U., Schedlowski, M., Meyer, U., & Engler, H. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.015 · Cited by 139 · see citing works

Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis

Capuzzi, E., Bartoli, F., Crocamo, C., Clerici, M., & Carrà, G. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.003 · Cited by 139 · see citing works

Maternal immune activation induces<i>GAD1</i>and<i>GAD2</i>promoter remodeling in the offspring prefrontal cortex

Labouesse, M. A., Dong, E., Grayson, D. R., Guidotti, A., & Meyer, U. (2015) · Epigenetics · doi:10.1080/15592294.2015.1114202 · Cited by 138 · see citing works

Regulation of Tetrahydrobiopterin Synthesis and Bioavailability in Endothelial Cells

Shi, W., Meininger, C. J., Haynes, T. E., Hatakeyama, K., & Wu, G. (2004) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:41:3:415 · Cited by 137 · see citing works

Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia

Rapaport, M. H., Delrahim, K. K., Bresee, C. J., Maddux, R. E., Ahmadpour, O. A., & Dolnak, D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.024 · Cited by 137 · see citing works

MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients

Dwir, D., Giangreco, B., Xin, L., Tenenbaum, L., Cabungcal, J.-H., Steullet, P., Goupil, A., Cleusix, M., Jenni, R., Chtarto, A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0393-5 · Cited by 137 · see citing works

TGFβ signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults

Kim, S. Y., Senatorov, V. V., Morrissey, C. S., Lippmann, K., Vazquez, O. N., Milikovsky, D. Z., Gu, F., Parada, I., Prince, D. A., Becker, A. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07394-3 · Cited by 136 · see citing works

Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood

Ibi, D., Nagai, T., Kitahara, Y., Mizoguchi, H., Koike, H., Shiraki, A., Takuma, K., Kamei, H., Noda, Y., Nitta, A., et al. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.03.015 · Cited by 135 · see citing works

The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies

Girgis, R. R., Kumar, S. S., & Brown, A. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.002 · Cited by 135 · see citing works

Clinical effects of COX?2 inhibitors on cognition in schizophrenia

M�ller, N., Riedel, M. J., Schwarz, M., & Engel, R. R. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0548-4 · Cited by 135 · see citing works

Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy

Meyer, U., Engler, A., Weber, L., Schedlowski, M., & Feldon, J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.031 · Cited by 135 · see citing works

Th17 Pathway-Mediated Immunopathogenesis of Schizophrenia: Mechanisms and Implications

Debnath, M., & Berk, M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu049 · Cited by 129 · see citing works

TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia

Goldsmith, D. R., Haroon, E., Miller, A. H., Strauss, G. P., Buckley, P. F., & Miller, B. J. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.048 · Cited by 128 · see citing works

Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages

Kwon, D.-J., Ju, S. M., Youn, G. S., Choi, S. Y., & Park, J. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.05.031 · Cited by 127 · see citing works

Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss

Bennett, M. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.003 · Cited by 126 · see citing works

Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages

Chiarugi, A., Calvani, M., Meli, E., Traggiai, E., & Moroni, F. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00418-0 · Cited by 125 · see citing works

Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation

Purves-Tyson, T. D., Weber‐Stadlbauer, U., Richetto, J., Rothmond, D. A., Labouesse, M. A., Polesel, M., Robinson, K., Weickert, C. S., & Meyer, U. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0434-0 · Cited by 125 · see citing works

Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine

Ribeiro, B. M. M., do Carmo, M. R. S., Freire, R. S., Rocha, N. F. M., Borella, V., Menezes, A. T., Monte, A. S., Gomes, P. X. L., de Sousa, F. C. F., Vale, M. L., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.040 · Cited by 123 · see citing works

Innate immune cells and C-Reactive protein in acute First-Episode psychosis and schizophrenia: relationship to psychopathology and treatment

Steiner, J., Frodl, T., Schiltz, K., Dobrowolny, H., Jacobs, R., Fernandes, B. S., Guest, P. C., Meyer-Lotz, G., Borucki, K., Bahn, S., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz068 · Cited by 123 · see citing works

Voltage compartmentalization in dendritic spines in vivo

Cornejo, V. H., Ofer, N., & Yuste, R. (2021) · Science · doi:10.1126/science.abg0501 · Cited by 120 · see citing works

Maternal immune activation induces sustained changes in fetal microglia motility

Ozaki, K., Kato, D., Ikegami, A., Hashimoto, A., Sugio, S., Guo, Z., Shibushita, M., Tatematsu, T., Haruwaka, K., Moorhouse, A. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78294-2 · Cited by 119 · see citing works

Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms

Cattane, N., Richetto, J., & Cattaneo, A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.001 · Cited by 118 · see citing works

Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology

Müller, N. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00045-a · Cited by 117 · see citing works

Imbalanced Kynurenine Pathway in Schizophrenia

Kegel, M. E., Bhat, M., Skogh, E., Samuelsson, M., Lundberg, K., Dahl, M., Sellgren, C., Schwieler, L., Engberg, G., Schuppe-Koistinen, I., et al. (2014) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s16800 · Cited by 116 · see citing works

Memory under stress: from single systems to network changes

Schwabe, L. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13478 · Cited by 114 · see citing works

S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia

Rothermundt, M., Ponath, G. D., Gläser, T., Hetzel, G., & Arolt, V. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300403 · Cited by 113 · see citing works

An analysis of dentate gyrus function (an update)

Kesner, R. P. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.033 · Cited by 113 · see citing works

C-reactive protein and all-cause mortality--the Copenhagen City Heart Study

Zacho, J., Tybjærg–Hansen, A., & Nordestgaard, B. G. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq103 · Cited by 112 · see citing works

Association of an Interleukin-1β Genetic Polymorphism With Altered Brain Structure in Patients With Schizophrenia

Meisenzahl, E. M., Rujescu, D., Kirner, A., Giegling, I., Kathmann, N., Leinsinger, G. L., Maag, K. P., Hegerl, U., Hahn, K. M., & Möller, H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1316 · Cited by 111 · see citing works

Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus

Litherland, S. A., Xie, X. T., Hutson, A. D., Wasserfall, C. H., Whittaker, D. S., She, J., Hofig, A., Dennis, M., Fuller, K. E., Cook, R. W., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4852 · Cited by 108 · see citing works

Cell adhesion and matricellular support by astrocytes of the tripartite synapse

Hillen, A. E. J., Burbach, J. P. H., & Hol, E. M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.02.002 · Cited by 108 · see citing works

The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view

Müller, N., & Schwarz, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_33 · Cited by 107 · see citing works

Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis

Gallego, J. A., Blanco, E. A., Husain-Krautter, S., Fagen, E. M., Moreno-Merino, P., del Ojo-Jiménez, J. A., Ahmed, A. O., Rothstein, T. L., Lencz, T., & Malhotra, A. K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.07.019 · Cited by 107 · see citing works

Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis

Misiak, B., Bartoli, F., Carrà, G., Stańczykiewicz, B., Gładka, A., Frydecka, D., Samochowiec, J., Jarosz, K., Hadryś, T., & Miller, B. J. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105200 · Cited by 107 · see citing works

HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment

Altamura, A. C., Boin, F., & Maes, M. H. J. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00017-6 · Cited by 106 · see citing works

Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis

Fraguas, D., Díaz‐Caneja, C. M., Rodríguez-Quiroga, A., & Arango, C. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx015 · Cited by 106 · see citing works

Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia

Parellada, E., & Gassó, P. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01385-9 · Cited by 106 · see citing works

Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders

Coiro, P., Padmashri, R., Suresh, A., Spartz, E., Pendyala, G., Chou, S., Jung, Y., Meays, B., Roy, S., Gautam, N., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.07.022 · Cited by 105 · see citing works

Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients

Endres, D., Perlov, E., Baumgärtner, A., Hottenrott, T., Dersch, R. S., Stich, O., & van Elst, L. T. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00476 · Cited by 102 · see citing works

Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27

Beadling, C., & Slifka, M. K. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0002-6 · Cited by 100 · see citing works

Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial Overactivation

Hu, X., Zhou, H., Zhang, D., Yang, S., Li, Q., Wu, H.-M., Chen, P.-S., Wilson, B. C., Gao, H., Lu, R., et al. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9309-0 · Cited by 100 · see citing works

Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment

De Simone, G., Mazza, B., Vellucci, L., Barone, A., Ciccarelli, M., & de Bartolomeis, A. (2023) · Antioxidants · doi:10.3390/antiox12040975 · Cited by 49 · see citing works

Temporal changes in brain morphology related to inflammation and schizophrenia: an omnigenic Mendelian randomization study

Liu, Y., Ren, H., Zhang, Y., Deng, W., Ma, X., Zhao, L., Li, X., Sham, P., Wang, Q., & Li, T. (2024) · Psychological Medicine · doi:10.1017/s003329172400014x · Cited by 15 · see citing works

Brain structure in schizophrenia: what do we know and what next?

Lawrie, S. M. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00172-5 · Cited by 7 · see citing works

Towards an Integrative Account of Potential Mechanisms Mediating the Path From Sleep Dysfunction to Hallucinations

Sheaves, B., Cropley, V. L., Moseley, P., Woodruff, P. W. R., Punton, G., Speth, C., Speth, J., Meerlo, P., & Brederoo, S. G. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf107 · Cited by 6 · see citing works

"Lipopolysaccharide-induced animal models for neuroinflammation – An overview."

Silva, A., Fiadeiro, M. B., Bernardino, L. I., Fonseca, C. P., Baltazar, G., & Cristóvão, A. C. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578273 · Cited by 76 · see citing works

Characterisation of ReNcells CX and VM stimulated with interleukin-1β and lipopolysaccharide

Cheung, K. A. K., Abeysinghe, P., Vaswani, K., et al. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105326 · Cited by 4 · see citing works

Role of Neuroinflammation in the Trajectory of Alzheimer’s Disease and in vivo Quantification Using PET

Edison, P., & Brooks, D. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179929 · Cited by 41 · see citing works

Neuroinflammation and oxidative injury in developmental neurotoxicity

Milatović, D., Zaja‐Milatovic, S., BREYER, R. M., Aschner, M., & Montine, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-382032-7.10064-5 · Cited by 13 · see citing works

Age-related effects of NMDA-stimulated concomitant release of nitric oxide and glutamate in cortical slices prepared from DBA/2 mice

Rowley, H. L., Ellis, Y., & Davies, J. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90452-s · Cited by 14 · see citing works